Tiny Redx Pharma Signs "Transformational" Cancer Deal With AstraZeneca PLC; Financial Terms Have Not Been Disclosed

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Early stage drug discovery group Redx Pharma has entered into a research collaboration with AstraZeneca. Neil Murray, Redx's chief executive, told Insider the agreement is "transformational" and part of the group's overall commercialisation strategy.

Under the terms of the collaboration, Redx Pharma scientists will work with AstraZeneca's Oncology Innovative Medicines group on a project to discover and develop new molecules targeting a genetic driver of tumour growth and survival.

Help employers find you! Check out all the jobs and post your resume.

Back to news